No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RNAZ Transcode Therapeutics
- 1.730
- +0.090+5.49%
Trading May 31 14:15 ET
11.46MMarket Cap0.00P/E (TTM)
1.795High1.662Low303.25KVolume1.700Open1.640Pre Close523.27KTurnover4.83%Turnover Ratio0.00P/E (Static)6.62MShares166.40052wk High2.50P/B10.86MFloat Cap0.42052wk Low--Dividend TTM6.28MShs Float5600.000Historical High--Div YieldTTM8.10%Amplitude0.420Historical Low1.725Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | TransCode Therapeutics Reports Data From First-in-Human Clinical Study Using TTX-MC138
Express News | Transcode Therapeutics:Data Support Belief That Clinical Development of Ttx-Mc138 Has Potential for Clinical Benefit in Patients With Metastatic Cancer
Express News | Transcode Therapeutics Reports Positive Data From First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, Ttx-Mc138
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSharps Technology (NASDAQ:STSS) shares rose 193.0% to $0.63 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.8 million. Insmed (NASDAQ:INSM) shares mov
12 Health Care Stocks Moving In Monday's Intraday Session
GainersInnovative Eyewear (NASDAQ:LUCY) shares moved upwards by 421.5% to $0.97 during Monday's regular session. The company's market cap stands at $16.9 million. OneMedNet (NASDAQ:ONMD) shares moved
LIDR, HOOK and BCAB Among Mid-day Movers
Comments
$Transcode Therapeutics(RNAZ.US$ is it a good time to buy or should I wait? I think it's gonna go up tomorrow.
1
$Transcode Therapeutics(RNAZ.US$
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
TransCode Therapeutics (NASDAQ: RNAZ) announced positive preliminary data from its Phase 0 clinical trial for TTX-MC138, their lead RNA-based therapeutic candidate. The trial showed significant inhibition of the molecular target miRNA-10b, with a 66% reduction in the patient's blood 24 hours post-administration. This inhibition is...
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
TransCode Therapeutics (NASDAQ: RNAZ) announced positive preliminary data from its Phase 0 clinical trial for TTX-MC138, their lead RNA-based therapeutic candidate. The trial showed significant inhibition of the molecular target miRNA-10b, with a 66% reduction in the patient's blood 24 hours post-administration. This inhibition is...
1
1
$Transcode Therapeutics(RNAZ.US$ what do you make of this pre-market activity ?
I am not a financial advisor
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
2
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
